Arun Menawat's most recent trade in Firefly Neuroscience Inc. was a trade of 125,000 Restricted Stock Units done . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Firefly Neuroscience Inc. | Arun Menawat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 125,000 | 125,000 | - | - | Restricted Stock Units | |
Profound Medical Corp | Arun Menawat | Director, CEO | Purchase of securities on an exchange or from another person at price $ 4.73 per share. | 15 May 2025 | 12,027 | 587,089 | - | 4.7 | 56,888 | Common Shares |
Profound Medical Corp | Arun Menawat | Director, CEO | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 15 May 2025 | 10,003 | 575,062 | - | 4.3 | 43,263 | Common Shares |
Firefly Neuroscience Inc. | Arun Menawat | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 16,667 | 16,667 | - | - | Deferred Stock Units |